M1069

N/A

Report date: 2025/05/09 15:53:46
NME

Base Information

Drug NameM1069
Drug Alias NameM-1069M1069
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor antagonistsAdenosine A2b receptor antagonists
TargetsAdenosine A2a receptorAdenosine A2b receptor
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck KGaA, Darmstadt, GermanyDomain Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmd Serono Research & Development Institute IncMerck KGaA, Darmstadt, Germany
Active IndicationsN/A
Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A